Hennion & Walsh Asset Management Inc. Acquires Shares of 2,240 HealthEquity, Inc. (NASDAQ:HQY)

Hennion & Walsh Asset Management Inc. bought a new position in shares of HealthEquity, Inc. (NASDAQ:HQY) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,240 shares of the company’s stock, valued at approximately $215,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in HQY. Envestnet Asset Management Inc. grew its holdings in HealthEquity by 7.1% during the 2nd quarter. Envestnet Asset Management Inc. now owns 115,614 shares of the company’s stock worth $9,966,000 after acquiring an additional 7,645 shares during the last quarter. Renaissance Technologies LLC bought a new stake in shares of HealthEquity during the second quarter valued at approximately $4,741,000. Vanguard Personalized Indexing Management LLC grew its stake in shares of HealthEquity by 8.8% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 7,730 shares of the company’s stock valued at $666,000 after purchasing an additional 626 shares during the last quarter. Hsbc Holdings PLC increased its holdings in shares of HealthEquity by 32.4% in the second quarter. Hsbc Holdings PLC now owns 91,969 shares of the company’s stock valued at $7,932,000 after purchasing an additional 22,508 shares in the last quarter. Finally, Intech Investment Management LLC bought a new position in HealthEquity in the 2nd quarter worth approximately $1,138,000. 99.55% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages have commented on HQY. Bank of America increased their price objective on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Barrington Research raised their price target on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a report on Monday, December 2nd. JMP Securities boosted their price objective on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a report on Tuesday, December 10th. Mizuho assumed coverage on shares of HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 target price on the stock. Finally, The Goldman Sachs Group assumed coverage on shares of HealthEquity in a research report on Friday, November 15th. They set a “neutral” rating and a $108.00 price target for the company. One research analyst has rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat, HealthEquity has an average rating of “Moderate Buy” and a consensus target price of $110.71.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $101.56, for a total value of $837,870.00. Following the transaction, the director now owns 66,469 shares of the company’s stock, valued at approximately $6,750,591.64. The trade was a 11.04 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Stuart B. Parker sold 25,000 shares of the stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the sale, the director now directly owns 19,061 shares of the company’s stock, valued at $1,843,579.92. This represents a 56.74 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 34,289 shares of company stock valued at $3,355,718. Company insiders own 2.20% of the company’s stock.

HealthEquity Stock Up 2.3 %

Shares of NASDAQ HQY opened at $104.74 on Wednesday. The firm has a 50 day moving average price of $99.04 and a 200 day moving average price of $86.92. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The stock has a market cap of $9.08 billion, a P/E ratio of 96.09, a P/E/G ratio of 1.80 and a beta of 0.54. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $105.82.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter last year, the business posted $0.40 earnings per share. Analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.